1. Improved glucose control with reduced hypoglycaemic risk when linagliptin is added to basal insulin in elderly patients with type 2 diabetes. Issue 9 (27th June 2015) Authors: Inzucchi, S. E.; Nauck, M. A.; Hehnke, U.; Woerle, H.‐J.; von Eynatten, M.; Henry, R. R. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 9(2015:Sep.) Page Start: 868 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy. Issue 10 (22nd June 2015) Authors: Inzucchi, S. E.; Tunceli, K.; Qiu, Y.; Rajpathak, S.; Brodovicz, K. G.; Engel, S. S.; Mavros, P.; Radican, L.; Brudi, P.; Li, Z.; Fan, C. P. S.; Hanna, B.; Tang, J.; Blonde, L. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 10(2015:Oct.) Page Start: 956 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function. Issue 12 (19th July 2013) Authors: Alba, M.; Ahrén, B.; Inzucchi, S. E.; Guan, Y.; Mallick, M.; Xu, L.; O'Neill, E. A.; Williams‐Herman, D. E.; Kaufman, K. D.; Goldstein, B. J. Journal: Diabetes, obesity & metabolism Issue: Volume 15:Issue 12(2013:Dec.) Page Start: 1101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗